Tirzepatide
What it is
Tirzepatide is a dual GIP and GLP-1 receptor agonist. Because it engages two incretin pathways at once, it sits between Semaglutide and Retatrutide in receptor coverage and is a key reference compound in metabolic and body-composition research.
What researchers study it for
- Dual GIP + GLP-1 receptor signalling
- Glucose- and lipid-metabolism models
- Body-composition and energy-expenditure research
- Incretin-pathway comparison studies
Purity & lab reports
Every Flux Labs batch of Tirzepatide ships with a Certificate of Analysis (COA) showing HPLC purity (typically 99%+) and mass-spectrometry confirmation. You can verify any batch number on our Verify page.
Reconstitution reference
Tirzepatide is supplied lyophilised and reconstituted with bacteriostatic water. Use our free Peptide Calculator to work out reference volumes and insulin-syringe units. All figures are research-reference values, not dosing advice.
Research-grade, 99%+ verified purity, COA included. Fast, discreet delivery across the UAE & GCC.
View Tirzepatide →Frequently asked questions
How is Tirzepatide different from Semaglutide?
Semaglutide targets the GLP-1 receptor only; Tirzepatide is a dual agonist that also engages the GIP receptor, so it is studied as a broader metabolic reference compound.
What sizes are available?
10 mg and 30 mg research vials, with multi-vial pack pricing. See the product page for current options.
Is a lab report included?
Yes — a COA with HPLC purity and mass-spec confirmation ships with every batch and is searchable on our Verify page.